18627 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:28 UTC
|
DUOL
Duolingo
|
◎ Target | Alec Brondolo ★★★☆☆ #1132 | Underweight | $82.00→ $80.00-2.4% |
|
Aug 08
11:28 UTC
|
DRVN
Driven Brands
|
◎ Target | Steven Shemesh ★★★★☆ #928 | Outperform | $17.00→ $16.00-5.9% |
|
Aug 08
11:28 UTC
|
DOCS
Doximity
|
◎ Target | Alexei Gogolev ★★★☆☆ #1194 | Neutral | $26.00→ $31.00+19.2% |
|
Aug 08
11:28 UTC
|
DNOW
DNOW
|
◎ Target | Charles Minervino ★★★☆☆ #1858 | Positive | $16.00→ $19.00+18.8% |
|
Aug 08
11:28 UTC
|
DNLI
Denali Therapeutics
|
◎ Target | Michael Yee ★★★★☆ #802 | Buy | $25.00→ $34.00+36.0% |
|
Aug 08
11:28 UTC
|
DKNG
DraftKings
|
◎ Target | Mike Hickey ★★★☆☆ #1980 | Buy | $29.00→ $30.00+3.4% |
|
Aug 08
11:28 UTC
|
DII.B
Dorel Industries
|
◎ Target | firm only | Hold | C$2.00→ C$1.50-25.0% |
|
Aug 08
11:28 UTC
|
DEI
Douglas Emmett
|
◎ Target | Richard Anderson ★★★★☆ #934 | Neutral | $12.00→ $13.00+8.3% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Karl Keirstead ★★★★☆ #541 | Buy | $315.00→ $280.00-11.1% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Mike Cikos ★★★★★ #7 | Buy | $260.00→ $300.00+15.4% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Fatima Boolani ★★★★★ #54 | Buy | $300.00→ $305.00+1.7% |
|
Aug 08
11:28 UTC
|
DD
DuPont de Nemours
|
◎ Target | Arun Viswanathan ★★★☆☆ #1412 | Outperform | $180.00→ $176.00-2.2% |
|
Aug 08
11:28 UTC
|
DCO
Ducommun
|
◎ Target | Ken Herbert not yet tracked | Sec→ r Perform ➝ Sector Performer | $175.00→ $200.00+14.3% |
|
Aug 08
11:28 UTC
|
DBX
Dropbox
|
◎ Target | Steven Enders not yet tracked | Neutral | $28.00→ $33.00+17.9% |
|
Aug 08
11:28 UTC
|
DASH
DoorDash
|
◎ Target | Shyam Patil ★★★★☆ #690 | Positive | $225.00→ $250.00+11.1% |
|
Aug 08
11:28 UTC
|
DASH
DoorDash
|
◎ Target | Ken Gawrelski ★★★★☆ #764 | Equal Weight | $199.00→ $225.00+13.1% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Colin Langan ★★★☆☆ #1901 | Equal Weight | $33.00→ $28.00-15.2% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Joseph Spak ★★★☆☆ #1098 | Buy | $39.00→ $38.00-2.6% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Tom Narayan ★★★☆☆ #1163 | Outperform | $33.00→ $37.00+12.1% |
|
Aug 08
11:28 UTC
|
CYTK
Cytokinetics
|
◎ Target | Leonid Timashev ★★★★☆ #366 | Outperform | $117.00→ $112.00-4.3% |
|
Aug 08
11:28 UTC
|
CYTK
Cytokinetics
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $105.00→ $110.00+4.8% |
|
Aug 08
11:28 UTC
|
CYTK
Cytokinetics
|
◎ Target | Serge Belanger ★★★★☆ #698 | Buy | $102.00→ $112.00+9.8% |
|
Aug 08
11:28 UTC
|
CYRX
CryoPort
|
◎ Target | Subbu Nambi ★★★★★ #124 | Buy | $12.00→ $16.00+33.3% |
|
Aug 08
11:28 UTC
|
CYRX
CryoPort
|
◎ Target | David Saxon ★★★★★ #275 | Buy | $15.00→ $19.00+26.7% |
|
Aug 08
11:28 UTC
|
CXW
CoreCivic
|
◎ Target | Bill Sutherland ★★★☆☆ #1158 | Buy | $41.00→ $45.00+9.8% |
|
Aug 08
11:28 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ricky Goldwasser not yet tracked | Overweight | $260.00→ $300.00+15.4% |
|
Aug 08
11:28 UTC
|
CRBP
Corbus Pharmaceuticals
|
◎ Target | Andres Y. Maldonado ★★★☆☆ #1409 | Buy | $40.00→ $35.00-12.5% |
|
Aug 08
11:28 UTC
|
CRBP
Corbus Pharmaceuticals
|
◎ Target | Jeff Jones ★★★★☆ #630 | Outperform | $52.00→ $48.00-7.7% |
|
Aug 08
11:28 UTC
|
CQP
Cheniere Energy Partners
|
◎ Target | Theresa Chen ★★★☆☆ #1936 | Underweight | $63.00→ $66.00+4.8% |
|
Aug 08
11:28 UTC
|
COR
Cencora
|
◎ Target | Erin Wright ★★★★☆ #855 | Overweight | $342.00→ $346.00+1.2% |
|
Aug 08
11:28 UTC
|
COR
Cencora
|
◎ Target | Lisa Gill ★★★☆☆ #1997 | Overweight | $382.00→ $390.00+2.1% |
|
Aug 08
11:28 UTC
|
COP
ConocoPhillips
|
◎ Target | Sam Margolin ★★★☆☆ #1542 | Overweight | $183.00→ $189.00+3.3% |
|
Aug 08
11:28 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Outperform | C$65.00→ C$66.00+1.5% |
|
Aug 08
11:28 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Buy | C$72.00→ C$73.00+1.4% |
|
Aug 08
11:28 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Sec→ r Perform | C$71.00→ C$73.00+2.8% |
|
Aug 08
11:28 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Biren Amin ★☆☆☆☆ #3015 | Overweight | $4.00→ $6.00+50.0% |
|
Aug 08
11:28 UTC
|
CMPS
Compass Pathways
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $70.00→ $65.00-7.1% |
|
Aug 08
11:28 UTC
|
CMC
Commercial Metals
|
◎ Target | Richard Garchitorena ★★★☆☆ #1396 | Equal Weight | $75.00→ $80.00+6.7% |
|
Aug 08
11:28 UTC
|
CLYM
Climb Bio
|
◎ Target | Danielle Brill ★★★☆☆ #1464 | Buy | $17.00→ $25.00+47.1% |
|
Aug 08
11:28 UTC
|
CLS
Celestica
|
◎ Target | Tim Long ★★★☆☆ #1422 | Overweight | $430.00→ $406.00-5.6% |
|
Aug 08
11:28 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Etzer Darout ★★★★☆ #915 | Overweight | $48.00→ $53.00+10.4% |
|
Aug 08
11:28 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★★★☆ #715 | Overweight | $40.00→ $46.00+15.0% |
|
Aug 08
11:28 UTC
|
CIFR
Cipher Mining
|
◎ Target | Richard Choe ★★☆☆☆ #2585 | Overweight | $23.00→ $22.00-4.3% |
|
Aug 08
11:28 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★★★☆☆ #1783 | Overweight | $26.00→ $33.00+26.9% |
|
Aug 08
11:28 UTC
|
CGON
CG Oncology
|
◎ Target | Leonid Timashev ★★★★☆ #366 | Outperform | $81.00→ $79.00-2.5% |
|
Aug 08
11:28 UTC
|
CGON
CG Oncology
|
◎ Target | Kelsey Goodwin ★★★☆☆ #1450 | Overweight | $82.00→ $85.00+3.7% |
|
Aug 08
11:28 UTC
|
CGON
CG Oncology
|
◎ Target | Gregory Renza ★★★☆☆ #1705 | Buy | $82.00→ $85.00+3.7% |
|
Aug 08
11:28 UTC
|
CGNX
Cognex
|
◎ Target | Jamie Cook ★★★☆☆ #1080 | Hold | $71.00→ $78.00+9.9% |
|
Aug 08
11:28 UTC
|
CGNX
Cognex
|
◎ Target | Troy Jensen ★★★★☆ #780 | Overweight | $76.00→ $84.00+10.5% |
|
Aug 08
11:28 UTC
|
CGNX
Cognex
|
◎ Target | James Ricchiuti ★★★☆☆ #982 | Buy | $75.00→ $80.00+6.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.